Abstract:Objective:To report a SPTLC2 gene mutation in a family with a phenotype of Charcot-Marie-Tooth disease.Methods:To screen the family of patients with pathogenic mutations of SPTLC2 gene from the database of hereditary peripheral neuropathy in the Department of Neurology, Peking University First Hospital, and to collect their clinical data, peripheral nerve conduction examination, nerve ultrasound examination, pathological examination of the peroneal nerve and whole exome sequencing results of prohand.Results:One family was screened, the proband was a 16-year-old female with 4 years of sensory loss and anhidrosis of both lower limbs and 16 months of walking difficulty who admitted to Peking University First Hospital in January 2022. Physical examination showed sensory loss, dry skin and weakness in distal limbs. Her father had numbness and dry skin in the distal lower limbs from childhood,weakness and atrophy of his lower limbs in adulthood. He died at age of 52 years old. The nerve conduction study revealed no action potentials of the sensory and motor nerves of the lower limbs in the proband. The amplitude of the compound muscle action potential of the motor conduction of the bilateral ulnar nerve and median nerve decreased, and the nerve conduction velocity of the bilateral median nerve were 32 m/s and 24 m/s. Neurosonography showed thickening of peripheral nerves. Sural biopsy revealed severe loss of myelinated and unmyelinated nerve fibers with onion bulbs formation. SPTLC2 gene showed a known heterozygous p.G435V mutation. The lower limb weakness was improved after oral L-serine.Conclusions:SPTLC2 gene mutation can lead to an intermediate Charcot-Marie-Tooth disease phenotype. L-serine can improve the limb weakness.

A Chronic Leg Ulcer Presenting with Charcot–Marie–Tooth Disease and Type 2 Diabetes

A Chronic Leg Ulcer Presenting With Charcot-Marie-Tooth Disease And Type 2 Diabetes: A Case Report (Vol 12, Pg 30, 2013)

Clinical Analysis of a Charcot-Marie-Tooth Disease Type 2F Family in China

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

A case report of type 1 diabetes mellitus coexistent with Charcot–Marie–Tooth type 1A and a literature review

Clinical and Genetic Characteristics of Charcot-Marie-Tooth Disease

A Novel Mutation of LRSAM1 in a Chinese Family with Charcot-Marie-Tooth Disease

[Analysis of the Pathological Features and Gene Mutations of Chinese Patients with Charcot-Marie-Tooth Disease].

The Clinical Features in Patients with Charcot-Marie-Tooth with PMP22 Duplication

A New Locus for Autosomal Dominant Charcot-Marie-Tooth Disease Type 2 (CMT2L) Maps to Chromosome 12Q24

Clinical,pathological and Genetic Studies in a Chinese Charcot-Marie-Tooth Disease Type 2 Family

Mutation Screening of Cx32 in Han Chinese Patients with Charcot-Marie-Tooth Disease.

Coexistent Charcot-Marie-Tooth Type 1A and Type 2 Diabetes Mellitus Neuropathies in a Chinese Family

Clinical, neurophysiological evaluation and genetic features of axonal Charcot–Marie–Tooth disease in a Chinese family

Clinical and Pathological Features in Charcot-Marie-Tooth Disease Type 2A2: a Family Report

A case report of peroneal muscle atrophy type 2A2 with central nervous system involvement as initial presentation

SPTLC2 gene mutation leads to intermediate Charcot-Marries-Tooth disease: a family report

Charcot-Marie-Tooth type 2CC misdiagnosed as Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Clinical features of autosomal recessive Charcot-Marie-Tooth disease 2K

CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase

Late Onset of Severe Demyelinating Peripheral Neuropathy in a 62-Year-Old African American Woman